Channel News Asia |
UPDATE 2-FDA panel backs Glaxo asthma drug for adults, not adolescents
Reuters The panel voted 16-4 that Breo Ellipta should be approved for once daily treatment of asthma in adults 18 years and older. It voted 19-1 that the data did not support approval for use in children aged 12 to 17. The FDA is not obliged to follow the … U.S. Panel Backs Glaxo's Breo for Adults With Asthma, Not Kids GSK's Breo for asthma? FDA panel says yes–but only in adults FDA panel backs Glaxo asthma drug for adults, not adolescents |
View full post on asthma – Google News